← Back to Clinical Trials
Recruiting NCT05899257

NCT05899257 Immersive Training on Metacognitive Capacities of Young People

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05899257
Status Recruiting
Phase
Sponsor University of Barcelona
Condition Self
Study Type INTERVENTIONAL
Enrollment 55 participants
Start Date 2023-05-01
Primary Completion 2026-05

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 29 Years
Study Type INTERVENTIONAL
Interventions
Immersive Training using EYME

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 55 participants in total. It began in 2023-05-01 with a primary completion date of 2026-05.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Metacognitive abilities and self-knowledge are necessary for psychological maturation and good mental functioning of individuals. It is generally agreed that an adequate representation of oneself and others is essential to establish functional interpersonal relationships. These metacognitive abilities are not adequately developed in patients with various mental health problems, such as personality disorders, eating disorders, psychosis, and depression, and are associated with the severity of the pathology. Self-awareness is a central element that begins to consolidate during adolescence. For that reason, the investigators aim to evaluate the effects of immersive training on the metacognitive abilities and self-knowledge of young people. Based on the repertory grid technique (RGT), our research team has developed a brief immersive training to enhance metacognitive abilities. This intervention facilitates the exploration of personal identity in a safe environment. Specifically, it is an immersion in the person's own world of meanings using Virtual Reality (VR), with the Explore Your Meanings (EYME) tool, a technological platform created to help mental health professionals to enhance the personal development and therapeutic change of their clients. Expected results include an increase in participants' self-concept clarity, metacognition, and reflective function as well as a deeper knowledge about their relationship with various aspects of self-knowledge and self-esteem.

Eligibility Criteria

Inclusion Criteria: * Volunteers between 18 and 29 years of age Exclusion Criteria: * Diagnosis of a mental disorder (current or in the last year) * Current psychological or psychiatric treatment * Suicidal ideation * Insufficient level of competence to communicate in Spanish or English

Contact & Investigator

Central Contact

Guillem Feixas, PhD

✉ gfeixas@ub.edu

📞 +34933125100

Principal Investigator

Guillem Feixas, PhD

PRINCIPAL INVESTIGATOR

University of Barcelona

Frequently Asked Questions

Who can join the NCT05899257 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 29 Years, studying Self. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05899257 currently recruiting?

Yes, NCT05899257 is actively recruiting participants. Contact the research team at gfeixas@ub.edu for enrollment information.

Where is the NCT05899257 trial being conducted?

This trial is being conducted at Barcelona, Spain.

Who is sponsoring the NCT05899257 clinical trial?

NCT05899257 is sponsored by University of Barcelona. The principal investigator is Guillem Feixas, PhD at University of Barcelona. The trial plans to enroll 55 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology